Natco Pharma Ltd vs Sanofi India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 10, 2026

Key Highlights

The Latest Trading Price of Natco Pharma Ltd is ₹ 1174 as of 08 May 15:30 . The p/e ratio of Natco Pharma Ltd changed from 34.2 to 7.6 over 5 quarters. This represents a CAGR of -69.98% The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The market cap of Natco Pharma Ltd changed from ₹ 15045 crore to ₹ 14287 crore over 5 quarters. This represents a CAGR of -4.05% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The revenue of Natco Pharma Ltd for the Dec '25 is ₹ 705.4 crore as compare to the Sep '25 revenue of ₹ 1463 crore. This represent the decline of -51.78% The revenue of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Natco Pharma Ltd for the Dec '25 is ₹ 216.8 crore as compare to the Sep '25 ebitda of ₹ 679.2 crore. This represent the decline of -68.08% The ebitda of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Natco Pharma Ltd changed from ₹ 668.5 crore to ₹ 140.4 crore over 7 quarters. This represents a CAGR of -59.01% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The dividend payout of Natco Pharma Ltd changed from 30.96 % to 5.8 % over 5 quarters. This represents a CAGR of -73.81% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% .

About Natco Pharma Ltd

Natco Pharma Ltd Share Price Overview Natco Pharma Ltd share price history highlights how the stock has evolved across different market cycles.
It reflects both company-specific developments and broader trends in the healthcare sector.
As a participant in this sector, the Natco Pharma Ltd share price movement is often influenced by factors such as drug regulations, generic demand, and changes in investor sentiment. Tracking its historical performance helps investors understand how the Natco Pharma share price has responded to earnings growth, economic shifts, and key business milestones over time. Long-Term Performance The Natco Pharma share price history has shown strong growth over different years.
Over the last five years, Natco Pharma Ltd share has delivered a CAGR of approximately 33.3%. The Natco share price reflects an upward trend, with a period of short-term volatility linked to earnings-related cycles, sector-specific factors, and broader market-sentiment shifts. Impact of Corporate Actions on Natco Pharma Ltd Share Price When analysing Natco Pharma Ltd share price history, it is important to account for corporate actions such as stock splits, bonus issues, and dividend payouts.
These events can adjust the Natco Pharma share price without affecting the company’s underlying value. Using adjusted historical prices provides a more accurate representation of long-term performance and investor returns. Factors Influencing Natco Pharma Ltd Share The following are the factors that may influence the Natco Pharma Ltd share price: Earnings Performance: Fluctuations in earnings due to variations in sales performance, margin, and generic approvals may affect the Natco Pharma share price directly. Order Book and Deal Wins: New order bookings and timely deal executions may have an effect on Natco Pharma Ltd share price performance. Healthcare Sector Growth: Increased demand in generics and policy support can help the Natco Pharma share price grow significantly. International Demand: International demand, especially in oncology drugs, may have a positive effect on Natco Pharma Ltd share revenues. Input Costs: Variations in input costs, like APIs and chemicals, may have an effect on Natco Pharma share profits. Currency Movement: Exchange rate changes may impact Natco Pharma Ltd share price through export revenues and input costs. Market Sentiment: Broader market trends, investor confidence and perception about the company can affect Natco Pharma share price behaviour. Why Check Share Price History of Natco Pharma Ltd Share? Here’s why reviewing the Natco Pharma Ltd share price history can be useful: Understanding Long-Term Trends: Historical data shows how the Natco Pharma share price has moved across different market cycles. Understanding Volatility: Past Natco Pharma Ltd share price movements provide an idea of how the stock behaves during market fluctuations. Comparison with Peers: Comparing performance with other healthcare companies can provide additional clarity. Support Investment Decisions: Reviewing past patterns helps in forming a more balanced and informed perspective. How to Analyse Share Price History of Natco Pharma Ltd Share? To analyse the Natco Pharma share history, individuals can follow the steps given below: Start With the Trend: Check whether the Natco Pharma share price has generally moved upward or experienced phases of consolidation and correction. Identify Support and Resistance: Observe price levels where the share price has previously stopped falling ‘support’ or faced selling pressure ‘resistance’. Analyse Volume: Check whether price movements are supported by higher trading volumes because stronger volume can indicate improved market participation. Utilise Technical Analysis Tools: Simple technical analysis tools, such as the moving average, can help one determine the trend direction and momentum of the Natco Pharma Ltd share price. Track Key Developments: Monitor earnings announcements, deal wins, and news to connect Natco Pharma share price changes with business events. Check Multiple Timeframes: Considering both short and long-term charts may help individuals provide more clarity and understanding of Natco Pharma Ltd share price movements. .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.

FAQs for the comparison of Natco Pharma Ltd and Sanofi India Ltd

Which company has a larger market capitalization, Natco Pharma Ltd or Sanofi India Ltd?

Market cap of Natco Pharma Ltd is 21,027 Cr while Market cap of Sanofi India Ltd is 8,111 Cr

What are the key factors driving the stock performance of Natco Pharma Ltd and Sanofi India Ltd?

The stock performance of Natco Pharma Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Natco Pharma Ltd and Sanofi India Ltd?

As of May 10, 2026, the Natco Pharma Ltd stock price is INR ₹1174.0. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.

How do dividend payouts of Natco Pharma Ltd and Sanofi India Ltd compare?

To compare the dividend payouts of Natco Pharma Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.